Incyte Corporation

Incyte is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. Our vision is to become a leader in the development and delivery of novel drugs for serious unmet medical needs. We have established multiple collaborations with major pharmaceutical companies to support the clinical development and global commercialization of several of our compounds. The Incyte corporate headquarters is located in Wilmington, Delaware, and more than 625 employees comprise our experienced management, discovery, clinical development and commercial teams. Our assets, experience and prior success in bringing important new drugs to market put us in a strong position to make a difference by improving the lives of patients and building sustainable value for our shareholders.
Company Growth (employees)
Type
Public
HQ
Wilmington, US
Founded
1991
Size (employees)
980 (est)
Website
incyte.com
Incyte Corporation was founded in 1991 and is headquartered in Wilmington, US

Incyte Corporation Office Locations

Incyte Corporation has offices in Wilmington, Genève, Geneva, Lausanne and in 7 other locations
Wilmington, US (HQ)
1801 Augustine Rd
Genève, CH
1 Rue du Pré-de-la-Bichette
Show all (11)

Incyte Corporation Financials and Metrics

Incyte Corporation Financials

Incyte Corporation's revenue was reported to be $1.1 b in FY, 2016
USD

Revenue (Q2, 2017)

326.4 m

Net income (Q2, 2017)

(12.5 m)

EBIT (Q2, 2017)

7.2 m

Market capitalization (13-Nov-2017)

22.8 b

Cash (30-Jun-2017)

451.8 m
Incyte Corporation's current market capitalization is $22.8 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

354.9 m511.5 m753.8 m1.1 b

Revenue growth, %

44%47%47%

R&D expense

581.9 m

General and administrative expense

303.3 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

85.1 m89.8 m99.6 m198.1 m159.3 m163 m187.6 m263.5 m246.3 m269.5 m384.1 m326.4 m

R&D expense

71.7 m75.6 m84.7 m88.5 m118.4 m112.4 m132.1 m156.8 m120.3 m143.2 m408 m201.8 m

General and administrative expense

26.4 m37 m40.9 m39.4 m44.9 m51.7 m47.6 m64.6 m66.8 m75.8 m87.2 m90.1 m

Operating expense total

98.3 m112.7 m125.8 m128.2 m166.2 m170.4 m187.7 m227.4 m201.7 m247.2 m517.4 m319.2 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

471.4 m452.3 m521.4 m652.3 m

Accounts Receivable

35.4 m57.9 m114.5 m148.8 m

Inventories

9.6 m20.5 m17.8 m4.1 m

Current Assets

555.8 m699.2 m842.4 m994.2 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

272.1 m436.6 m406.3 m382 m421.8 m439.7 m445.8 m657.6 m487.7 m580.1 m361.8 m451.8 m

Accounts Receivable

33.2 m46.4 m47.2 m109.6 m69.6 m75.1 m87 m101.3 m129.5 m131.5 m245 m169.5 m

Inventories

359 k347 k269 k402 k2.4 m1.9 m2.4 m1.3 m6.1 m4.1 m4 m2.9 m

Current Assets

333.7 m581.2 m577.1 m662.6 m692.1 m733 m757.9 m935.6 m792.1 m886.7 m819.2 m844.8 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(83.1 m)(48.5 m)6.5 m104.2 m

Depreciation and Amortization

58.4 m

Accounts Receivable

35.6 m(23 m)114 m(23.9 m)

Inventories

(6.6 m)(4.1 m)17.8 m4 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(22 m)(34 m)(36.9 m)59.3 m(18.4 m)(39.6 m)24 m34.4 m36.9 m(187.1 m)

Accounts Receivable

47.2 m109.6 m69.6 m75.1 m87 m101.3 m129.5 m131.5 m245 m

Inventories

269 k402 k2.4 m1.9 m2.4 m1.3 m6.1 m4.1 m4 m

Accounts Payable

27.3 m26.6 m26.6 m29.2 m27.4 m31.9 m40.7 m57.5 m86.3 m
Y, 2017

Financial Leverage

1.6 x
Show all financial metrics

Incyte Corporation Market Value History

Incyte Corporation Median Salaries

Source: 40 public H-1B filings from Incyte Corporation

Incyte Corporation's Web-traffic and Trends

Incyte Corporation Online and Social Media Presence

Incyte Corporation Company Life and Culture

You may also be interested in